Top Markets
#1 Akedo Akedo +70.44%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.33%
#4 Cross Cross +45.97%
#5 Velvet Velvet +34.78%
#6 Black Phoenix Black Phoenix +34.22%
#7 OVERTAKE OVERTAKE +21.57%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.16%
#9 Movement Movement +13.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.14%
Coin of the day
Akedo Akedo
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Niki BioSolutions, Inc. Niki BioSolutions, Inc.

Niki BioSolutions, Inc.

NIKI
Rang în acțiuni #38980
Niki BioSolutions is a biopharmaceutical company that resulted from the merger... Niki BioSolutions is a biopharmaceutical company that resulted from the merger of Aptorum Group and DiamiR Biosciences. The company focuses on developing and commercializing a diverse portfolio of therapeutic and diagnostic assets. Its work spans from treatments for diseases with unmet medical needs, particularly in oncology and infectious diseases, to the development of innovative, blood-based diagnostic tests for brain health and other conditions.
Preț acțiune
$8.69
Capitalizare de piață
$707.69K
Schimbare (1 zi)
3.82%
Schimbare (1 an)
-94.05%
Țară
US
Tranzacționează Niki BioSolutions, Inc. (NIKI)

Categorie

Healthcare
Raport P/S pentru Niki BioSolutions, Inc. (NIKI)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Niki BioSolutions, Inc., raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru Niki BioSolutions, Inc. din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE